Investor Relations

Corporate Overview

LENZ Therapeutics is a pre-commercial biopharmaceutical company focused on the development and commercialization of the first and only aceclidine-based eye drop to improve near vision in people with presbyopia.

Latest Financial Results

Q1 2025

Quarter Ended Mar 31, 2025

News Icon

Latest News

LENZ Therapeutics to Present at Upcoming Investor Conferences

Events Icon

Upcoming Event

Jefferies Global Healthcare Conference

IR Contacts

Corporate

LENZ Therapeutics, Inc.
201 Lomas Santa Fe Drive
Suite 300
Solana Beach, CA 92075
T: (888) 928-LENZ (5369)
contact@lenz-tx.com

Investor Relations

LENZ Therapeutics
IR@LENZ-Tx.com

Transfer Agent

Equiniti Trust Company, LLC
48 Wall Street
New York, NY 10005
T: 800-937-5449

Connect With Us